PWPS
RXRX icon

Pinnacle Wealth Planning Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67K Buy
1,196
+1,029
+616% +$3.98K ﹤0.01% 2322
2025
Q4 		$683 Buy
+167
New +$827 ﹤0.01% 2624

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Wealth Planning Services's RXRX Position: Q1 2026 in Review

Pinnacle Wealth Planning Services increased its Recursion Pharmaceuticals (RXRX) stake by 616% in Q1 2026, buying an estimated $3.98K and bringing the position to 1,196 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

Pinnacle Wealth Planning Services first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Pinnacle Wealth Planning Services held 1,196 shares of Recursion Pharmaceuticals worth $3.67K as of Q1 2026.
  • Pinnacle Wealth Planning Services bought 1,029 Recursion Pharmaceuticals shares in Q1 2026, an estimated $3.98K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2322 holding.
  • Pinnacle Wealth Planning Services first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.